486 related articles for article (PubMed ID: 15689496)
1. TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition.
Valcourt U; Kowanetz M; Niimi H; Heldin CH; Moustakas A
Mol Biol Cell; 2005 Apr; 16(4):1987-2002. PubMed ID: 15689496
[TBL] [Abstract][Full Text] [Related]
2. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.
Zeisberg M; Hanai J; Sugimoto H; Mammoto T; Charytan D; Strutz F; Kalluri R
Nat Med; 2003 Jul; 9(7):964-8. PubMed ID: 12808448
[TBL] [Abstract][Full Text] [Related]
3. Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1).
Pardali K; Kowanetz M; Heldin CH; Moustakas A
J Cell Physiol; 2005 Jul; 204(1):260-72. PubMed ID: 15690394
[TBL] [Abstract][Full Text] [Related]
4. Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein.
Kowanetz M; Valcourt U; Bergström R; Heldin CH; Moustakas A
Mol Cell Biol; 2004 May; 24(10):4241-54. PubMed ID: 15121845
[TBL] [Abstract][Full Text] [Related]
5. TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells.
Piek E; Moustakas A; Kurisaki A; Heldin CH; ten Dijke P
J Cell Sci; 1999 Dec; 112 ( Pt 24)():4557-68. PubMed ID: 10574705
[TBL] [Abstract][Full Text] [Related]
6. Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways.
Davies M; Robinson M; Smith E; Huntley S; Prime S; Paterson I
J Cell Biochem; 2005 Aug; 95(5):918-31. PubMed ID: 15861394
[TBL] [Abstract][Full Text] [Related]
7. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition.
Zavadil J; Cermak L; Soto-Nieves N; Böttinger EP
EMBO J; 2004 Mar; 23(5):1155-65. PubMed ID: 14976548
[TBL] [Abstract][Full Text] [Related]
8. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
9. Collaborative activities of macrophage-stimulating protein and transforming growth factor-beta1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase.
Wang D; Shen Q; Chen YQ; Wang MH
Oncogene; 2004 Mar; 23(9):1668-80. PubMed ID: 15001985
[TBL] [Abstract][Full Text] [Related]
10. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
11. A component of the ARC/Mediator complex required for TGF beta/Nodal signalling.
Kato Y; Habas R; Katsuyama Y; Näär AM; He X
Nature; 2002 Aug; 418(6898):641-6. PubMed ID: 12167862
[TBL] [Abstract][Full Text] [Related]
12. Developmental expression of Smad1-7 suggests critical function of TGF-beta/BMP signaling in regulating epithelial-mesenchymal interaction during tooth morphogenesis.
Xu X; Jeong L; Han J; Ito Y; Bringas P; Chai Y
Int J Dev Biol; 2003 Feb; 47(1):31-9. PubMed ID: 12653249
[TBL] [Abstract][Full Text] [Related]
13. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12.
Lee KS; Kim HJ; Li QL; Chi XZ; Ueta C; Komori T; Wozney JM; Kim EG; Choi JY; Ryoo HM; Bae SC
Mol Cell Biol; 2000 Dec; 20(23):8783-92. PubMed ID: 11073979
[TBL] [Abstract][Full Text] [Related]
14. Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification.
Sakou T; Onishi T; Yamamoto T; Nagamine T; Sampath Tk; Ten Dijke P
J Bone Miner Res; 1999 Jul; 14(7):1145-52. PubMed ID: 10404014
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway.
You L; Kruse FE
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):72-81. PubMed ID: 11773015
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition.
Thuault S; Valcourt U; Petersen M; Manfioletti G; Heldin CH; Moustakas A
J Cell Biol; 2006 Jul; 174(2):175-83. PubMed ID: 16831886
[TBL] [Abstract][Full Text] [Related]
17. BMP-7 fails to attenuate TGF-beta1-induced epithelial-to-mesenchymal transition in human proximal tubule epithelial cells.
Dudas PL; Argentieri RL; Farrell FX
Nephrol Dial Transplant; 2009 May; 24(5):1406-16. PubMed ID: 19056781
[TBL] [Abstract][Full Text] [Related]
18. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
19. Expression of TGF-beta related Smad proteins in human epithelial skin tumors.
Lange D; Persson U; Wollina U; ten Dijke P; Castelli E; Heldin CH; Funa K
Int J Oncol; 1999 Jun; 14(6):1049-56. PubMed ID: 10339656
[TBL] [Abstract][Full Text] [Related]
20. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.
Zhang Y; Musci T; Derynck R
Curr Biol; 1997 Apr; 7(4):270-6. PubMed ID: 9094310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]